Evaluation of neoadjuvant inhibition of aromatase activity and signal transduction in breast cancer. [electronic resource]
- Cancer letters Apr 2008
- 232-8 p. digital
Publication Type: Clinical Trial; Journal Article
0304-3835
10.1016/j.canlet.2007.12.003 doi
Aged Antineoplastic Combined Chemotherapy Protocols--adverse effects Aromatase Inhibitors Benzamides Breast Neoplasms--drug therapy Carcinoma, Ductal, Breast--drug therapy Chemotherapy, Adjuvant Drug Evaluation Female Humans Imatinib Mesylate Letrozole Middle Aged Neoadjuvant Therapy Neoplasms, Hormone-Dependent--drug therapy Nitriles--therapeutic use Pilot Projects Piperazines--therapeutic use Postmenopause Pyrimidines--therapeutic use Signal Transduction Triazoles--therapeutic use